Friday, July 31, 2026

Inside North Korea’s English-Speaking Tours: Harry Potter, Beer Jokes, and Fluent English?

The Pyongyang International Marathon highlights North Korean tour guides' impressive English skills and evolving tourism dynamics.

Shaperon to Expand Biobeauty Business With NeedsTech, Targeting Hong Kong, Taiwan and U.S. Markets

Shaperon is acquiring NeedsTech to enhance its biobeauty business and expand globally, targeting markets in Hong Kong, Taiwan, and the U.S.

How New Law Will Transform Human-Derived Fat into High-Value Bio-Materials

Human-derived fat, once medical waste, is now a valuable resource for biotech after new legislation allows its recycling for regenerative medicine.

Tag: development

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Discover the First-Ever 5-in-1 Calcium and Vitamin D Supplement: What You Need to Know About ‘Adtaminjeong’

Bukwang Pharmaceutical launches Edtamin Tablet, a supplement with calcium and vitamins to support nerve function and fetal development.

JW Pharmaceutical Secures Phase 1 Approval for Novel Hair Loss Treatment JW0061—What to Expect?

JW Pharmaceutical is investing in innovative hair loss treatments and expanding its drug portfolio, including successful cholesterol medications.

Boehringer Ingelheim’s People Promise: How HR Innovation is Shaping the Future of Work in Asia

Boehringer Ingelheim emphasizes a people-centered strategy, focusing on talent mobility, leadership development, and diversity in the Asia-Pacific region.

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

Lunit and Selcarta Join Forces: Accelerating AI Biomarker Companion Diagnostics in 2026

Lunit partners with Selcarta to enhance AI-based biomarkers for diagnostics, aiming to streamline clinical trials and accelerate drug development.

FDA’s Game-Changing Guidelines: What Asian Biotech Firms Must Know About Clinical Trial Efficiency

Clinical Trial Design is crucial for success in pharma; FDA's new rules could ease burdens but raise quality standards.

National AI Strategy Committee Partners With Cisco on AI Security and Talent Development

The National AI Strategy Committee collaborates with Cisco on AI security and talent development, prioritizing a safe AI ecosystem.

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

How the Late Lee Kun-hee’s 700 Billion Won Donation is Transforming Infectious Disease Research in Korea

The KDCA will host two international symposia on infectious disease research to enhance collaboration and response capabilities starting March 26.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

KT Partners with KOSA to Elevate AI Certification Standards in 2026

KT partners with KOSA to enhance AI literacy and improve the AICE certification, aiming to cultivate industry-relevant AI talent.

How 80% Faster AI Analysis is Revolutionizing Healthcare

Koo Hyuk-jae visits BioNexus to explore AI's role in biomedical research, aiming to revolutionize drug development and diagnostics.

How GCCL and KBIOHealth’s New Agreement Will Transform Clinical Trials in South Korea

GCCL signs MOU with KBIOHealth to enhance clinical research and drug development, integrating public research with industry expertise.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.